Literature DB >> 15155996

C-reactive protein in the diagnosis of melioidosis.

Allen C Cheng1, Matthew Obrien, Susan P Jacups, Nicholas M Anstey, Bart J Currie.   

Abstract

Previous work suggested that C-reactive protein (CRP) may be a useful test in the diagnosis of melioidosis, the infection caused by Burkholderia pseudomallei. We reviewed patients with culture-confirmed melioidosis to define the role of this inflammatory marker in the diagnosis of melioidosis. In 175 patients, we found that the admission CRP level may be normal or only mildly elevated, including patients with severe sepsis, fatal cases, and in relapsed melioidosis. In a multivariate analysis, sepsis and bacteremia were more strongly associated with mortality than CRP. Admission levels of CRP are not a sensitive marker for the presence of melioidosis and a normal level cannot be used to exclude acute, chronic, or relapsed melioidosis in febrile patients in or from endemic regions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155996

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  8 in total

1.  Serum C-reactive protein and liver disease in patients with melioidosis.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Intensive Care Med       Date:  2007-01-30       Impact factor: 17.440

2.  Clinical Utility of Platelet Count as a Prognostic Marker for Melioidosis.

Authors:  Philippa Kirby; Simon Smith; Linda Ward; Josh Hanson; Bart J Currie
Journal:  Am J Trop Med Hyg       Date:  2019-05       Impact factor: 2.345

Review 3.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

4.  Calprotectin as a Biomarker for Melioidosis Disease Progression and Management.

Authors:  Mohan Natesan; Enoka Corea; Shivankari Krishnananthasivam; Harindra Darshana Sathkumara; Jennifer L Dankmeyer; Beverly K Dyas; Kei Amemiya; Aruna Dharshan De Silva; Robert G Ulrich
Journal:  J Clin Microbiol       Date:  2017-02-08       Impact factor: 5.948

5.  Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.

Authors:  Kevin L Schully; Matthew G Bell; Jerrold M Ward; Andrea M Keane-Myers
Journal:  PLoS One       Date:  2014-12-11       Impact factor: 3.240

6.  Increased Von Willebrand factor, decreased ADAMTS13 and thrombocytopenia in melioidosis.

Authors:  Emma Birnie; Gavin C K W Koh; Ester C Löwenberg; Joost C M Meijers; Rapeephan R Maude; Nicholas P J Day; Sharon J Peacock; Tom van der Poll; W Joost Wiersinga
Journal:  PLoS Negl Trop Dis       Date:  2017-03-15

7.  Risk Factors for Mortality in Melioidosis: A Single-Centre, 10-Year Retrospective Cohort Study.

Authors:  Raviraj Menon; Poornima Baby; Anil Kumar V; Sandeep Surendran; Manu Pradeep; Aiswarya Rajendran; Gaayathri Suju; Arathy Ashok
Journal:  ScientificWorldJournal       Date:  2021-07-05

Review 8.  The Treatment of Melioidosis.

Authors:  Timothy J J Inglis
Journal:  Pharmaceuticals (Basel)       Date:  2010-04-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.